DBV Technologies S.A. DBVT
$ 3.18
4.26%
Quarterly report 2024-Q3
added 11-06-2024
Country |
France |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Daniel Tass |
Employees in the company |
311 |
Shares |
95.1 M |
Market Cap[1] |
$ 302 M |
EBITDA (LTM) |
$ -83 M |
P/E (LTM) |
-0.69 |
P/S (LTM) |
12.18 |
EPS (LTM) |
-1.11 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.